Insight Molecular Diagnostics Ord Shs

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Insight Molecular Diagnostics Ord Shs had 28.20M in cash and cash equivalents.

Insight Molecular Diagnostics Ord Shs reported 57.22M in total liabilities as of the latest reported quarter, including 12.07M in current liabilities and 45.15M in non-current liabilities.

As of the latest reported quarter, Insight Molecular Diagnostics Ord Shs's total assets were 25.76M, consisting of 15.31M in current assets and 10.45M in non-current assets.

Insight Molecular Diagnostics Ord Shs reported -31.46M in total shareholders' equity as of the latest reported quarter.